MAFG and obesity disorder: To corroborate our findings of improved metabolic control upon Mafg silencing during obesity using independent approaches, we repeated our RNAi studies using N-acetyl galactosamine (GalNAc)-conjugated Mafg and Control antisense oligonucleotide (ASO) inhibitors.